BOTULINUM NEUROTOXIN TYPE A (CLOSTRIDIUM BOTULINUM (STRAIN HALL / ATCC 3502 / NCTC 13319 / TYPE A))
UNII 23Q86Z38EX

Substance Identification & Data

This profile provides standardized clinical and technical data for Botulinum Neurotoxin Type A (clostridium Botulinum (strain Hall / Atcc 3502 / Nctc 13319 / Type A)), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23Q86Z38EX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 93384-43-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
23Q86Z38EX
CAS Registry Number
93384-43-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BOTULINUM NEUROTOXIN TYPE A (CLOSTRIDIUM BOTULINUM (STRAIN HALL / ATCC 3502 / NCTC 13319 / TYPE A))
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Botulinum Neurotoxin Type A (clostridium Botulinum (strain Hall / Atcc 3502 / Nctc 13319 / Type A)). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

BOTULINUM NEUROTOXIN TYPE A (CLOSTRIDIUM BOTULINUM (STRAIN HALL / ATCC 3502 / NCTC 13319 / TYPE A))